Impulse Control Disorder
Showing 1 - 25 of >10,000
Emotion Regulation, Mood Disorders, Stress Disorder Trial in Durham (Active Repetitive Transcranial Magnetic Stimulation (rTMS),
Not yet recruiting
- Emotion Regulation
- +13 more
- Active Repetitive Transcranial Magnetic Stimulation (rTMS)
- +3 more
-
Durham, North CarolinaDuke University Medical Center
Jan 25, 2023
Alcohol Use Disorder, Intermittent Explosive Disorder Trial in Columbus (Alcohol (Ethanol), Placebo)
Recruiting
- Alcohol Use Disorder
- Intermittent Explosive Disorder
- Alcohol (Ethanol)
- Placebo
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Nov 1, 2023
Intermittent Explosive Disorder Trial in Columbus (Nitrous oxide, Room Air)
Recruiting
- Intermittent Explosive Disorder
- Nitrous oxide
- Room Air
-
Columbus, OhioOhio State University Wexner Medical Center
Nov 1, 2023
Impulse Control Disorder Trial in Korea, Republic of (Levodopa/Carbidopa(200mg/50mg), Dopaminergic Agonists)
Completed
- Impulse Control Disorder
- Levodopa/Carbidopa(200mg/50mg)
- Dopaminergic Agonists
-
Anyang, Korea, Republic of
- +4 more
Mar 9, 2021
Intermittent Explosive Disorder Trial in Columbus (Pimavanserin 34 mg, Placebo)
Not yet recruiting
- Intermittent Explosive Disorder
- Pimavanserin 34 mg
- Placebo
-
Columbus, OhioThe Ohio State University College of Medicine
May 31, 2023
Bipolar Affective Disorder Trial in Moscow (Quetiapine)
Recruiting
- Bipolar Affective Disorder
-
Moscow, Russian FederationMental health research center
Oct 18, 2021
Modified DECIDE Intervention, Treatment as Usual Care Group Trial in Indianapolis (Modified DECIDE Parent and Provider
Recruiting
- Modified DECIDE Intervention
- Treatment as Usual Care Group
- Modified DECIDE Parent and Provider Intervention
-
Sarasota, Florida
- +4 more
Oct 31, 2022
Parkinson's Disease, Mpulse Control Disorders Trial in Bron (, Clonidine)
Completed
- Parkinson's Disease
- Mpulse Control Disorders
- placebo
- Clonidine
-
Bron, FranceHospices Civils de Lyon
Jan 18, 2022
Intermittent Explosive Disorder Trial in Chicago (Fluoxetine, Divalproex, Placebo)
Completed
- Intermittent Explosive Disorder
- Fluoxetine
- +2 more
-
Chicago, IllinoisThe University of Chicago
Apr 26, 2021
Intermittent Explosive Disorder Trial in Philadelphia (Cognitive Bias Modification, Cognitive Bias Control)
Not yet recruiting
- Intermittent Explosive Disorder
- Cognitive Bias Modification
- Cognitive Bias Control
-
Philadelphia, PennsylvaniaTemple University
Mar 25, 2021
Chronic Pain, Knee Pain Chronic, Back Pain, Low Trial in San Francisco (HFIT, TENS, Control)
Not yet recruiting
- Chronic Pain
- +2 more
- HFIT
- +2 more
-
San Francisco, CaliforniaHinge Health, Inc
Apr 18, 2023
Binge-Eating Disorder Trial in Tübingen (Behavioral training and verum stimulation, Behavioral training and sham stimulation)
Completed
- Binge-Eating Disorder
- Behavioral training and verum stimulation
- Behavioral training and sham stimulation
-
Tübingen, GermanyUniversity Hospital Tübingen
May 23, 2022
Attention Deficit/Hyperactivity Disorder Trial in Boston (Oxytocin nasal spray, Placebo nasal spray)
Completed
- Attention Deficit/Hyperactivity Disorder
- Oxytocin nasal spray
- Placebo nasal spray
-
Boston, MassachusettsMassachusetts General Hospital
Nov 30, 2022
PTSD Trial (Transcranial Magnetic Stimulation (TMS))
Not yet recruiting
- PTSD
- Transcranial Magnetic Stimulation (TMS)
- (no location specified)
Aug 30, 2023
ADHD, Executive Dysfunction Trial (Goal Management training)
Not yet recruiting
- Attention Deficit Hyperactivity Disorder
- Executive Dysfunction
- Goal Management training
- (no location specified)
May 26, 2023
OCD in Children Trial in New York (Cognitive Control Training (CT))
Not yet recruiting
- Obsessive-Compulsive Disorder in Children
- Cognitive Control Training (CT)
-
New York, New YorkNew York State Psychiatric Institute
Oct 22, 2023
Parkinson Disease Trial in France (drug, behavioral, procedure)
Recruiting
- Parkinson Disease
- Active drug: pimavanserin 17mg (2 strength tablets)
- +9 more
-
Besançon, France
- +15 more
Jan 20, 2022
Vestibular Disorder Trial (Vestibular training using VR followed by Control, Control followed by Vestibular training using VR)
Not yet recruiting
- Vestibular Disorder
- Vestibular training using VR followed by Control
- Control followed by Vestibular training using VR
- (no location specified)
Jul 10, 2023
Multispectral Optoacoustic Tomography in Cystic Fibrosis
Not yet recruiting
- Cystic Fibrosis
- +3 more
- Acoustic Radiation Forced Impulse Imaging
- Multispectral Optoacoustic Tomography
-
Erlangen, Bavaria, GermanyUniversity Hospital Erlange, Department of Pediatrics
Sep 25, 2023
Bipolar Disorder, Bipolar I Disorder, Bipolar Affective Disorder Trial in Chicago (Cognitive Control of Emotion (CCE) Training)
Completed
- Bipolar Disorder
- +4 more
- Cognitive Control of Emotion (CCE) Training
-
Chicago, IllinoisRush University Medical Center
Jan 12, 2023
Autism Spectrum Disorder Trial (Postural Control Balance Assessment)
Completed
- Autism Spectrum Disorder
- Postural Control Balance Assessment
- (no location specified)
Dec 8, 2022
MDD Trial in San Francisco (Intervention app, Control app)
Not yet recruiting
- Major Depressive Disorder
- Intervention app
- Control app
-
San Francisco, CaliforniaBig Health, Inc.
Aug 29, 2023
Tourette Disorder Trial in Bron, Paris (Administration of a PET radiotracer)
Not yet recruiting
- Tourette Disorder
- Administration of a PET radiotracer
-
Bron, France
- +1 more
Jul 12, 2023
Attentional Biases, Reward Sensitivity, and Cognitive Control in
Recruiting
- Bipolar Disorder
- Eye tracking
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center - Mood Disorders P
Sep 29, 2022
Teenagers, Drug Addiction, and Reward and Impulse Control
Withdrawn
- Adolescents
- +2 more
- (no location specified)
Dec 11, 2019